The RIA Prospecting
Power Center

How Independent Advisors Use ERS Ratings to Win Clients

Let the arithmetic make the argument.

The Arithmetic Most Advisors Never Perform

Every registered investment advisor makes the same promise: superior advice, fiduciary care, risk management. Few can prove it. The reason is structural. Most RIAs rely on the same sell-side research, the same analyst consensus estimates, and the same backward-looking performance data that every other advisor uses. The result is undifferentiated prospecting — and prospects know it.

Consider what a prospective client actually holds when they walk into your office. A typical portfolio of 25 to 40 individual equity positions accumulated over years of brokerage advice, 401(k) elections, and personal picks. Some of those positions carry measurable, identifiable risk characteristics that can be quantified before a single dollar changes hands. But without a systematic method for identifying those risks, the advisor's pitch reduces to personality and promises.

ERS ratings change that equation. They give you a quantitative language for risk that your competitor does not have — and that your prospect's current advisor has never used.

The Four Core Ratings

ERS produces independent, conflict-free stock risk ratings built on 25 years of historical data. Four ratings form the core of the prospecting toolkit. Each measures a distinct dimension of risk. Together, they give an advisor something no Wall Street research report provides: a multi-dimensional probability assessment of what is likely to happen to a given stock.

Fiduciary Stock Navigator™ (FSN)

The flagship composite rating. Integrates financial statement analysis, valuation metrics, momentum signals, and loss-probability indicators into a single score that answers the threshold question every fiduciary must ask: Does this stock meet the minimum standard of care for a prudent investor? In a 25-year backtested study, stocks rated FSN-favorable produced annualized returns of approximately 21%*, compared with approximately 9% for the S&P 500.

Loss Indicator™ (LI)

Flags stocks carrying elevated downside exposure based on a composite of financial, valuation, and behavioral signals. When the LI rates a position unfavorable, the historical record shows those stocks significantly underperform — giving you a documented, quantitative basis to raise the conversation about risk with a prospect before losses materialize.

Price Risk Indicator™ (PRI)

Measures current price risk relative to historical norms. Answers a question that P/E ratios alone cannot: Is this stock's current price sustainable, given the full constellation of financial, momentum, and volatility inputs? A stock with a favorable P/E but an unfavorable PRI is a stock whose price is running ahead of its fundamentals.

4 Dimensions of Risk™ (4D)

Integrates four independent analytical lenses: financial strength, valuation discipline, earnings momentum, and price behavior. During bear market periods specifically, the performance differential widened — precisely when risk management matters most to a client. The 4D is the rating that proves your risk discipline does not disappear when markets turn.

* The 21% annualized return figure was generated using an earlier, superseded version of the ERS ratings. The study validates the directional methodology; it does not project current platform performance.

Rating What It Measures Prospect Application
FSN Composite fiduciary suitability Identify which holdings meet the standard of care
LI Forward loss probability Quantify downside risk in specific holdings
PRI Current price sustainability Flag overextended positions
4D Multi-dimensional risk composite Demonstrate all-weather risk discipline

The 5-Step ERS Prospecting Workflow

Each step has a defined input, a defined output, and a measurable effect on the prospect conversation.

1

Harvest the Prospect's Current Holdings

Before any meeting, obtain the prospect's current portfolio. Sources include a recent brokerage statement, a 401(k) summary, or public holdings. If the prospect resists sharing a full statement, request only the top 10 to 15 equity positions by market value — that captures the majority of their risk exposure.

2

Run the Full ERS Rating Scan

Enter each ticker into the ERS system and pull the FSN, LI, PRI, and 4D ratings. Pay special attention to positions where multiple ratings are unfavorable simultaneously. A stock with an unfavorable FSN, an elevated LI, and a negative PRI is carrying concentrated, multi-dimensional risk — and it is almost certainly a position the prospect's current advisor has never analyzed this way.

3

Build the Risk Elimination Report

Sort the prospect's holdings into three categories: (a) positions where all four ratings are favorable or neutral, (b) positions where one or two ratings are unfavorable, and (c) positions where three or four ratings are unfavorable. Category (c) is your prospecting ammunition. For each, prepare a one-paragraph summary: the stock name, the specific unfavorable ratings, the historical loss probability, and the price-risk assessment.

4

Present the Arithmetic, Not a Pitch

In the prospect meeting, do not lead with your firm's AUM, your investment philosophy, or your fee schedule. Lead with the Risk Elimination Report. Open with: "I ran your portfolio through an independent risk rating system. Here is what the arithmetic says." Walk through the category (c) positions one by one. Do not editorialize. Let the numbers carry the argument.

5

Propose the Replacement Framework

For each category (c) holding, identify one or two replacement candidates from the same sector that carry favorable ERS ratings across all four dimensions. Present these as a side-by-side comparison. This is not a recommendation to buy or sell. It is a demonstration of a systematic process — a process the prospect's current advisor does not have.

Three Advisor Scripts

Each script follows the same principle: state the arithmetic, let the prospect react, and answer the question they ask next — not the question you wish they would ask.

Script 1: The Opening Statement

First Prospect Meeting — Portfolio in Hand

"Before we talk about anything else, I want to show you something I prepared. I took the holdings from your portfolio and ran them through an independent stock risk rating system called ERS. It's not affiliated with any brokerage, any fund company, or any bank. It has no conflicts of interest. It rates stocks on four dimensions: fiduciary suitability, loss probability, price risk, and a composite measure of financial strength, valuation, momentum, and price behavior."

"Out of your [X] equity positions, [Y] of them carry unfavorable ratings on three or four of these dimensions simultaneously. That means the independent arithmetic says these positions carry elevated, measurable risk. I'd like to walk you through those positions, one at a time, and show you what the numbers say."

Script 2: The Risk Rating Conversation

Addressing a Specific High-Risk Holding

"Let's look at [Stock Name]. Your position is approximately $[X]. The ERS Loss Indicator rates this stock as carrying elevated downside risk. The Price Risk Indicator says the current price is running ahead of what the fundamentals support. And the Fiduciary Stock Navigator rates it unfavorable overall. Three independent ratings, all pointing in the same direction."

"I'm not telling you to sell it. What I'm telling you is that the independent arithmetic says this position carries elevated, measurable risk that your current advisor may not have identified. The question isn't whether you trust my opinion. The question is whether you'd like someone managing your money who performs this kind of analysis before buying or holding any stock."

Script 3: The Competitive Differentiation Close

End of Meeting

"Here's what I want you to take away from today. Every advisor you meet will tell you they manage risk. Very few can show you the arithmetic. What I've shown you today is a systematic, independent, conflict-free analysis of every equity position in your portfolio — rated on four dimensions, backed by 25 years of historical data."

"The question you should ask your current advisor is simple: 'Can you show me, for each stock in my portfolio, the historical loss probability and the independent risk rating?' If they can't answer that question, they're managing your money without performing the arithmetic that a fiduciary is obligated to perform. I can show you that arithmetic for every stock, every day."

Why Risk Avoidance Is the Competitive Advantage

The advisory industry has conditioned clients to evaluate advisors on returns. This is a mistake — both mathematically and strategically. A portfolio that loses 30% must then gain 43% merely to return to its starting value. A portfolio that avoids the 30% loss needs no recovery at all. The arithmetic of loss avoidance is asymmetric, and it favors the advisor who can identify risk before it materializes.

ERS ratings provide the systematic infrastructure for that identification. Consider a prospect whose portfolio contains five positions with unfavorable FSN ratings, elevated LI scores, and overextended PRI readings. That prospect is not merely holding risky stocks. That prospect is holding stocks whose risk is independently measurable, historically quantified, and — critically — avoidable. The advisor who can demonstrate this analysis has a structural advantage over every competitor who cannot.

This is not about predicting the future. It is about measuring the present. The ERS ratings do not claim to know which stocks will decline. They quantify the probability of decline based on 25 years of observed outcomes. That distinction matters to sophisticated prospects, and it matters even more to compliance departments, to attorneys reviewing fiduciary obligations, and to the advisors who take those obligations seriously.

The Arithmetic in Practice

Imagine a prospect with a $2 million equity portfolio distributed across 30 positions. After running the ERS scan, you identify seven positions — representing approximately $520,000 in market value — that carry unfavorable ratings on three or four dimensions simultaneously.

If those seven positions were to decline by 20%, the portfolio-level impact is approximately $104,000 in unrealized losses. Replacing those positions with sector-equivalent holdings that carry favorable ERS ratings across all four dimensions materially reduces the concentration of measurable risk in the portfolio.

Metric Before (Current Holdings) After (ERS-Rated Replacements)
High-risk positions 7 of 30 0 of 30
Capital at elevated risk $520,000 $0
ERS risk rating status Unfavorable on 3–4 dimensions Favorable on all 4 dimensions
If those positions decline 20% ~$104,000 at risk Materially reduced exposure

This illustration uses hypothetical figures for demonstration purposes. Actual results depend on individual portfolio composition, market conditions, and the timing of analysis. Past performance of rating systems does not guarantee future results.

Fiduciary Resources

SEC guidance, ERS research, and practical frameworks for understanding and fulfilling your fiduciary obligations.

Equity Risk Sciences™ (ERS) is an independent stock risk rating agency. ERS ratings are analytical tools, not investment recommendations. The historical performance data cited on this page reflects the backtested results of rules-based rating systems applied to historical market data. Backtested results are hypothetical and do not represent actual trading. Past performance, whether actual or backtested, does not guarantee future results. All investment involves risk, including the possible loss of principal. RIAs should perform their own independent analysis and consult with compliance counsel before incorporating any third-party rating system into their advisory practice.

Run Your First Prospect's Portfolio
Through the ERS Ratings.

The trial includes full access to FSN, LI, PRI, and 4D ratings.
No credit card. No obligation. The arithmetic will speak for itself.

Start Your Free 30-Day Trial